Neumora Therapeutics, Common Stock Analysis

Neumora Stock Analysis Notes

About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.04. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neumora Therapeutics, recorded a loss per share of 1.2. The entity had not issued any dividends in recent years. To find out more about Neumora Therapeutics, Common contact Henry Gosebruch at 857 760 0900 or learn more at https://www.neumoratx.com.

Neumora Therapeutics, Investment Alerts

Neumora Therapeutics, Upcoming and Recent Events

Neumora Largest EPS Surprises

View All Earnings Estimates

Neumora Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 332.82 M.

Neumora Profitablity

Management Efficiency

Neumora Therapeutics, has return on total asset (ROA) of (0.3775) % which means that it has lost $0.3775 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7708) %, meaning that it created substantial loss on money invested by shareholders. Neumora Therapeutics,'s management efficiency ratios could be used to measure how well Neumora Therapeutics, manages its routine affairs as well as how well it operates its assets and liabilities. As of January 23, 2025, Return On Tangible Assets is expected to decline to -0.45. In addition to that, Return On Capital Employed is expected to decline to -0.38. At present, Neumora Therapeutics,'s Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 28.2 M, whereas Total Assets are forecasted to decline to about 340.9 M.

Technical Drivers

As of the 23rd of January, Neumora Therapeutics, secures the Standard Deviation of 11.29, mean deviation of 5.25, and Risk Adjusted Performance of (0.11). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neumora Therapeutics,, as well as the relationship between them.

Neumora Therapeutics, Price Movement Analysis

Neumora Therapeutics, Insider Trading Activities

Neumora Therapeutics, Predictive Daily Indicators

Neumora Therapeutics, Corporate Filings

Neumora Therapeutics, Forecast Models

Neumora Therapeutics,'s time-series forecasting models are one of many Neumora Therapeutics,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neumora Therapeutics,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Neumora Therapeutics, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Neumora shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Neumora Therapeutics,. By using and applying Neumora Stock analysis, traders can create a robust methodology for identifying Neumora entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Neumora analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Neumora analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Neumora Therapeutics, Common stock analysis indicators help investors evaluate how Neumora Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Neumora Therapeutics, shares will generate the highest return on investment. By understating and applying Neumora Therapeutics, stock analysis, traders can identify Neumora Therapeutics, position entry and exit signals to maximize returns.

When running Neumora Therapeutics,'s price analysis, check to measure Neumora Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neumora Therapeutics, is operating at the current time. Most of Neumora Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Neumora Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neumora Therapeutics,'s price. Additionally, you may evaluate how the addition of Neumora Therapeutics, to your portfolios can decrease your overall portfolio volatility.